Verified peer comparison
Supernus Pharmaceuticals vs EPR Properties Financial Comparison
Direct answer
Supernus Pharmaceuticals and EPR Properties are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Net income, Operating cash flow.
Alpha Vantage
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Supernus Pharmaceuticals Revenue
- 718,952,000 USD
- EPR Properties Revenue
- 718,357,000 USD
- Supernus Pharmaceuticals Net income
- -38,550,000 USD
- EPR Properties Net income
- 274,936,000 USD